Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1991 5
1992 1
1993 1
1994 2
1995 3
1996 2
1997 2
1998 2
1999 4
2001 2
2002 3
2003 6
2004 17
2005 17
2006 10
2007 10
2008 10
2009 16
2010 21
2011 22
2012 29
2013 30
2014 23
2015 15
2016 11
2017 12
2018 19
2019 15
2020 29
2021 29
2022 22
2023 24
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

379 results

Results by year

Filters applied: . Clear all
Page 1
Long COVID across SARS-CoV-2 variants, lineages, and sublineages.
Padilla S, Ledesma C, García-Abellán J, García JA, Fernández-González M, de la Rica A, Galiana A, Gutiérrez F, Masiá M. Padilla S, et al. Among authors: masia m. iScience. 2024 Mar 19;27(4):109536. doi: 10.1016/j.isci.2024.109536. eCollection 2024 Apr 19. iScience. 2024. PMID: 38585665 Free PMC article.
Mitochondrial Haplogroups and Weight Gain After Initiating ART in Patients with HIV.
Berenguer J, Jarrín I, Bellón JM, Díez C, Jiménez-Sousa MA, López JC, Pinto-Martínez A, Moreno S, Montes ML, Iribarren JA, Orviz E, Portilla J, Villarroya F, Domingo P, Resino S; CoRIS cohort. Berenguer J, et al. J Infect Dis. 2024 Apr 1:jiae168. doi: 10.1093/infdis/jiae168. Online ahead of print. J Infect Dis. 2024. PMID: 38557859
Switching to dolutegravir plus rilpivirine versus maintaining current antiretroviral therapy regimen in virologically suppressed people with HIV-1 and the Lys103Asn (K103N) mutation: 48-week results from a randomised, open-label pilot clinical trial.
Moyle G, Assoumou L, de Castro N, Post FA, Curran A, Rusconi S, De Wit S, Stephan C, Raffi F, Johnson M, Masia M, Vera J, Jones B, Grove R, Fletcher C, Duffy A, Morris K, Pozniak A; NEAT ID Foundation and the WISARD study group. Moyle G, et al. Among authors: masia m. Lancet HIV. 2024 Mar;11(3):e156-e166. doi: 10.1016/S2352-3018(23)00292-8. Lancet HIV. 2024. PMID: 38417976 Clinical Trial.
Cancer screening in people with HIV: Implementation in clinical practice and barriers perceived by medical specialists in Spain.
Gutiérrez F, Padilla S, García-Abellán J, Gutiérrez-Ortiz de la Tabla A, Ledesma C, Masiá M. Gutiérrez F, et al. Among authors: masia m. Enferm Infecc Microbiol Clin (Engl Ed). 2024 Jan 22:S2529-993X(24)00013-3. doi: 10.1016/j.eimce.2024.01.007. Online ahead of print. Enferm Infecc Microbiol Clin (Engl Ed). 2024. PMID: 38262880
Transmitted drug resistance to antiretroviral drugs in Spain during the period 2019-2021.
Viñuela L, de Salazar A, Fuentes A, Serrano-Conde E, Falces-Romero I, Pinto A, Portilla I, Masiá M, Peraire J, Gómez-Sirvent JL, Sanchiz M, Iborra A, Baza B, Aguilera A, Olalla J, Espinosa N, Iribarren JA, Martínez-Velasco M, Imaz A, Montero M, Rivero M, Suarez-García I, Maciá MD, Galán JC, Perez-Elias MJ, García-Fraile LJ, Moreno C, Garcia F. Viñuela L, et al. Among authors: masia m. J Med Virol. 2023 Dec;95(12):e29287. doi: 10.1002/jmv.29287. J Med Virol. 2023. PMID: 38084763 Free article.
Cancer screening in people living with HIV.
Masiá M, Gutiérrez-Ortiz de la Tabla A, Gutiérrez F. Masiá M, et al. Cancer Med. 2023 Nov;12(21):20590-20603. doi: 10.1002/cam4.6585. Epub 2023 Oct 25. Cancer Med. 2023. PMID: 37877338 Free PMC article. Review.
Correction: Impact of an enhanced screening program on the detection of non-AIDS neoplasias in patients with human immunodeficiency virus infection.
Masiá M, Padilla S, Estañ G, Portu J, Silva A, Rivero A, González-Cordón A, García-Fraile L, Martínez O, Bernal E, Galera C, Martínez VB, Macias J, Montero M, García-Rosado D, Vivancos-Gallego MJ, Llenas-García J, Torralba M, García JA, Agulló V, Fernández-González M, Gutiérrez F, Martínez E; IMPAC-NEO Study Group. Masiá M, et al. Trials. 2023 Sep 27;24(1):614. doi: 10.1186/s13063-023-07655-9. Trials. 2023. PMID: 37759269 Free PMC article. No abstract available.
379 results